Latest News - Chemence Medical, Inc.

25
Feb

Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive

Alpharetta, Georgia – February 15, 2016

Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell Exofin®, a new topical skin adhesive for wound closure. Exofin enters the market as the fastest polymerizing 2-octyl cyanoacrylate topical adhesive available and as the highest viscosity formulation in the industry. Read more